Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine

被引:52
|
作者
Wilcox, Susan R. [1 ]
Kabrhel, Christopher [1 ]
Channick, Richard N. [2 ]
机构
[1] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02114 USA
关键词
CHEST COMPUTED-TOMOGRAPHY; ARTERIAL-HYPERTENSION; HEART-FAILURE; MANAGEMENT STRATEGIES; NATRIURETIC PEPTIDE; NITRIC-OXIDE; DIAGNOSIS; NOREPINEPHRINE; DYSFUNCTION; PATIENT;
D O I
10.1016/j.annemergmed.2015.07.525
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pulmonary hypertension is a hemodynamic condition, defined as a mean pulmonary artery pressure by right-sided heart catheterization of at least 25 mm Hg at rest. It is classified into 5 general groups based on the underlying cause, with left ventricular failure and chronic obstructive pulmonary disease being 2 of the most common causes in the United States. Although the specifics of the pathophysiology will vary with the cause, appreciating the risks of pulmonary hypertension and right ventricular failure is critical to appropriately evaluating and resuscitating pulmonary hypertension patients in the emergency department (ED). Patients may present to the ED with complaints related to pulmonary hypertension or unrelated ones, but this condition will affect all aspects of care. Exertional dyspnea is the most common symptom attributable to pulmonary hypertension, but the latter should be considered in any ED patient with unexplained dyspnea on exertion, syncope, or signs of right ventricular dysfunction. Patients with right ventricular failure are often volume overloaded, and careful volume management is imperative, especially in the setting of hypotension. Vasopressors and inotropes, rather than fluid boluses, are often required in shock to augment cardiac output and reduce the risk of exacerbating right ventricular ischemia. Intubation should be avoided if possible, although hypoxemia and hypercapnia may also worsen right-sided heart function. Emergency physicians should appreciate the role of pulmonary vasodilators in the treatment of pulmonary arterial hypertension and recognize that patients receiving these medications may rapidly develop right ventricular failure and even death without these therapies. Patients may require interventions not readily available in the ED, such as a pulmonary artery catheter, inhaled pulmonary vasodilators, and mechanical support with a right ventricular assist device or extracorporeal membrane oxygenation. Therefore, early consultation with a pulmonary hypertension specialist and transfer to a tertiary care center with invasive monitoring and mechanical support capabilities is advised.
引用
收藏
页码:619 / 628
页数:10
相关论文
共 50 条
  • [21] Proteomic Signature of Right Ventricular Failure in Pulmonary Arterial Hypertension
    Yokokawa, Tetsuro
    Shimauchi, Tsukasa
    Bonnet, Sandra B.
    Potus, Francois
    Paulin, Roxane
    Provencher, Steeve
    Bonnet, Sebastien
    Boucherat, Olivier
    CIRCULATION, 2021, 144
  • [22] Progression of right ventricular failure in pulmonary hypertension is associated with reduced right ventricular mechanical efficiency
    Wong, Y. Y.
    Ruiter, G.
    Lubberink, M.
    Knaapen, P.
    Raijmakers, P.
    Marcus, J. T.
    Boonstra, A.
    Westerhof, N.
    Van der Laarse, W. J.
    Vonk-Noordegraaf, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A88 - A89
  • [23] Percutaneous right ventricular assist device in sepsis due to right ventricular failure and pulmonary hypertension
    Hansen, L. N.
    Berg, H.
    Schmidt, H.
    Veien, K. T.
    Jensen, M. K.
    Junker, A.
    Moller, J. E.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2016, 60 (10) : 1470 - 1472
  • [24] Spontaneous Ventricular Fibrillation in Right Ventricular Failure Secondary to Chronic Pulmonary Hypertension
    Umar, Soban
    Lee, Jong-Hwan
    de Lange, Enno
    Iorga, Andrea
    Partow-Navid, Rod
    Bapat, Aneesh
    van der Laarse, Arnoud
    Saggar, Rajeev
    Saggar, Rajan
    Ypey, Dirk L.
    Karagueuzian, Hrayr S.
    Eghbali, Mansoureh
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (01): : 181 - U305
  • [25] Right Ventricular Pulmonary Hypertension
    Marco Guazzi
    Serenella Castelvecchio
    Francesco Bandera
    Lorenzo Menicanti
    Current Heart Failure Reports, 2012, 9 (4) : 303 - 308
  • [26] PREFERRED VASOACTIVE IN THE SETTING OF RIGHT VENTRICULAR FAILURE CAUSED BY PULMONARY HYPERTENSION
    Spezzano, Katherine
    Costello, Patrick
    Sokol, Sarah
    Patel, Sajni
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 623 - 623
  • [27] Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
    Jimenez Cabrera, Oscar Gabriel
    Rene Pulido-Zamudio, Tomas
    Guadalupe Zayas-Hernandez, Nayeli
    Cesar Lopez-Reyes, Julio
    Sandoval-Zarate, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Management of right ventricular failure in pulmonary hypertension (and after LVAD Implantation)
    Palmer B.
    Lampert B.
    Mathier M.A.
    Current Treatment Options in Cardiovascular Medicine, 2013, 15 (5) : 533 - 543
  • [29] Bendopnea Predicts Right Ventricular Energy Failure in Patients with Pulmonary Hypertension
    Akaslan, Dursun
    Aslanger, Emre
    Basa, Chasan Ismail
    Ozturk, Ruken
    Atas, Halil
    Mutlu, Buelent
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (07): : 440 - 446
  • [30] Emerging role of epigenetic in pulmonary arterial hypertension right ventricular failure
    Potus, Francois
    Ruffenach, Gregoire
    Provencher, Steeve
    Bonnet, Sebastien
    FASEB JOURNAL, 2015, 29